Koyfin Home > Directory > Health Care > Acorda Therapeutics > Return on Capital %

Acorda Therapeutics Return on Capital % Chart (ACOR)

Acorda Therapeutics annual/quarterly Return on Capital % from 2010 to 2020.
  • Acorda Therapeutics Return on Capital % for the quarter ending June 06, 2020 was -11.19 a 8.21% decrease of -0.92 year over year
  • Acorda Therapeutics Return on Capital % for the last 12 months ending June 06, 2020 was -8.61 a -8.41% increase of 0.72 year over year
  • Acorda Therapeutics Annual Return on Capital % for 2019 was -9.61 a 168.06% decrease of -16.16 from 2018
  • Acorda Therapeutics Annual Return on Capital % for 2018 was 6.54 a -16.10% decrease of -1.05 from 2017
  • Acorda Therapeutics Annual Return on Capital % for 2017 was 7.60 a 108.51% increase of 8.24 from 2016
Other Margins & Efficiency Metrics:
  • Acorda Therapeutics EBITDA Margin for the quarter ending December 12, 2018 was $-20m a 159.12% decrease of -32m year over year
  • Acorda Therapeutics Return on Equity % for the quarter ending December 12, 2018 was 6.34 a 196.69% increase of 12.47 year over year
View Chart On Koyfin

Quarterly ACOR Return on Capital % Data

06/2020-11.19
03/2020-14.43
12/2019-4.78
09/2019-10.27
06/2019-9.65
03/2019-9.45
12/2018-3.93
09/201813.52
06/201814.19
03/20181.91

Annual ACOR Return on Capital % Data

2019-9.61
20186.54
20177.60
2016-0.65
20153.28
20144.47
20134.69
20125.31
201116.67
2010-3.48